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Abstract Corynebacterium ulcerans is mainly known for
its ability to cause animal infections. Some strains of
C. ulcerans produce diphtheria toxin, which can cause life-
threatening cardiopathies and neuropathies in humans.
Human cutaneous C. ulcerans infection is a very rare dis-
ease that mimics classical cutaneous diphtheria. We present
a very rare case of a C. ulcerans skin infection caused by a
non-diphtheria toxin-producing strain of C. ulcerans that
resolved after 3 weeks of therapy with amoxicillin–cla-
vulanate. A pet cat was the probable source of infection.
The presence of C. ulcerans in the mouth of the cat was
confirmed by 16S rRNA gene analysis and the API Coryne
system. In cases of human infection with potentially toxi-
genic corynebacteria, it is important to determine the spe-
cies and examine the isolate for diphtheria toxin production.
If toxigenicity is present, diphtheria antitoxin should be
administered immediately. Carriers and potential infectious
sources of C. ulcerans include not only domestic livestock
but also pet animals. For the primary prevention of disease
caused by diphtheria toxin-producing corynebacteria, vac-
cination with diphtheria toxoid is recommended.
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Introduction
Corynebacterium ulcerans is primarily known as an animal
pathogen and is a commensal in horses and cattle [1]. In
veterinary medicine, it is a recognized cause of mastitis in
cows and has been isolated from raw cow’s milk. Zoonotic
human infections have been reported, usually among rural
populations with direct contact to domestic livestock [1].
The global epidemiology of human infections caused by
C. ulcerans is not well understood [2]. Many strains of
C. ulcerans produce the diphtheria toxin [3] and cause
exudative pharyngitis in humans indistinguishable from
diphtheria [4], with local pseudomembrane production and
potential systemic cardiac or neurologic manifestations as
life-threatening complications. Independently of diphtheria
toxin production, some strains produce a dermonecrotic
toxin [5]. Skin infections caused by C. ulcerans have very
rarely been reported so far (Table 1). As in this reported
case, the clinical manifestation is undistinguishable from
classical cutaneous diphtheria [1, 6].
Case report
A 29-year-old otherwise healthy male developed a cuta-
neous ulcer on the right hand measuring about 1 cm in
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diameter with undermined elevated edges, covered with a
gray–brown membrane (Fig. 1). In addition, on the back of
his hand and over the fourth and fifth fingers, there was a
clearly outlined area of erythema (Fig. 1). No signs of
lymphangitis or lymphadenopathy were detected and the
patient did not report any other symptoms. The laboratory
findings, including the inflammatory markers (C-reactive
protein [CRP] 1.5 mg/l and leukocytes 9.40 9 109/l) and
the antistreptolysin titer, were normal. We took a swab
from the lesion and started oral therapy with amoxicillin–
clavulanate (625 mg, three times a day). Culture of the
swab on 5 % sheep blood agar produced a growth of nor-
mal skin flora and, as major pathogens, Enterococcus
species and dry waxy colonies of Gram-positive rods were
subsequently identified as C. ulcerans by the API Coryne
system (bioMe´rieux, Gene`ve, Switzerland) and by a posi-
tive fermentation test for glycogen and trehalose. Real-time
polymerase chain reaction (PCR) analysis for the presence
of the diphtheria toxin gene [7] using chromosomal DNA
extracted from the C. ulcerans isolate was negative, indi-
cating the lack of diphtheria toxin production. The patient
had been vaccinated with diphtheria toxoid 10 years earlier
during military service. The general condition of the
patient remained good for the duration of the treatment
and, as he showed no signs of cardiopathy or neuropathy,
diphtheria antitoxin titration or administration was thought
not to be necessary.
The course of the patient’s disease was favorable and,
after 3 weeks of unchanged systemic antibiotic therapy and
local antisepsis with aqueous chlorhexidine 0.1 % lotion,
we noticed a remarkable improvement of the lesion on the
hand, resulting in defect healing with a scar.
On further inquiry, the patient remembered an episode
of sore throat and fever 3 weeks before the appearance of
the cutaneous lesion. Swabs taken from the throat of the
patient 2 weeks after the end of antibiotic therapy produced
only the growth of normal flora. The patient denied any
contacts with horses or cows but the pet cat of the patient
had lesions similar to the patient in its mouth and on a paw
1 week earlier. The cat’s veterinarian clinically suspected a
neoplasm or a bullous skin disease and, therefore, per-
formed two skin biopsies that revealed a suppurative skin
infection with edema of the dermis and an infiltration of
neutrophils (Fig. 2). Broad-range bacterial 16S rRNA gene
PCR [8] using an extract of the paraffin-embedded tissue
did not detect bacterial DNA. However, this could be due
to reduced sensitivity of the PCR in formalin-fixed, par-
affin-embedded tissue [9]. The cat received systemic
therapy with clindamycin (5.5 mg/kg body weight every
12 h orally for 32 days), which resulted in complete
regression of all lesions.
Subsequently, about 2 weeks after the end of clinda-
mycin therapy, we took a swab from the mouth of the
cat; Gram-positive rods identified as C. ulcerans or
C. pseudotuberculosis were isolated on a 5 % sheep blood
agar-based selective medium containing fosfomycin.
Coryneform colonies were examined by 16S rRNA gene
analysis and the API Coryne system. The sequence was
submitted to GenBank under accession number
Table 1 Reported cases of Corynebacterium ulcerans skin infections
Reference Year Number of
patients
Country Toxigenic
strain
Wagner et al. [6] 2001 1 Germany Uncertain
DeWinter et al. [22] 2005 3 Canada Yes
Werchniak et al. [23] 2007 1 USA Yes
Fig. 1 Ulcer of 1 cm in diameter with undermined edges, covered
with a gray–brown membrane. Erythema on the back of the right hand
and over the fourth and fifth fingers (lower inset photograph)
Fig. 2 Biopsy specimen of the cat’s lips revealing a suppurative
mucosal infection with edema of the dermis and an infiltration of
neutrophils. HE 910 and 940
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HM136582. The 16S rRNA gene sequence showed 100 %
homology with C. ulcerans. There was also a high
homology (99.7 %) to C. pseudotuberculosis, requiring a
further analysis for species assignment. Using the API
Coryne system, the isolate was identified as C. ulcerans
with a percentage identification value of 99.7 % and
T-index value of 1. Both the analysis for the production of
diphtheria toxin and PCR for Parapoxvirus, Orthopoxvirus,
and Orf virus resulted negative.
Discussion
There is no evidence of human-to-human transmission of C.
ulcerans [1, 6], but rare cases of familial infection have been
detected [10]. In addition to domestic livestock, pet cats and
dogs were recently suggested as possible carriers and
transmission sources of this pathogen [11, 12]. Our case
supports this conjecture. In the reported case, the domestic
cat had suffered a cutaneous infection resembling the
patient’s lesion. After antibiotic therapy, the cat was found to
be carrying C. ulcerans in the mouth, suggesting that it may
have been the source of the patient’s infection. As cultures
were no longer available, molecular typing and comparison
of the human and feline isolates was not possible. Never-
theless, the time course and the close contact suggest pos-
sible zoonotic transmission. Probably, the normal flora of the
cat’s mouth will overcome C. ulcerans as a normal patho-
physiologic process [13]. Similarly to the prevention of
pasteurellosis [14], hygienic precautions, such as the
avoidance of contact of skin lesions with cat saliva and the
use of appropriate antisepsis and disinfection procedures, are
to be observed for a minimal transmission risk.
The microbiological diagnosis of C. ulcerans can be
performed by culture from a swab of the infection site
using the procedures fully described in the World Health
Organization (WHO) ‘‘Manual for the laboratory diagnosis
of diphtheria’’ [15]. The microorganism can be distin-
guished from C. diphtheriae and C. pseudotuberculosis
with a conventional biochemical kit test (e.g., API Coryne
system) [16]. After the identification of the correct species,
an evaluation of diphtheria toxin production is recom-
mended for all organisms that have the potential to produce
this toxin. It is known that the ability to produce diphtheria
toxin is carried in the structural gene, tox, mediated by
infection of the bacterium by a corynebacteriophage [17].
Rapid methods such as PCR have improved the identifi-
cation of the diphtheria toxin gene [15]. Not all PCR-
positive strains of C. diphtheriae have a biologically active
tox gene and express phenotypically the toxin [18]. Nev-
ertheless, tox gene-positive but non-toxigenic strains of
C. ulcerans have, so far, not been documented [6]. In our
case, we used a real-time PCR for the detection of
toxigenicity; however, a recent study has suggested that
false-negative results may be obtained by this method [19].
For this reason, an additional test to check for diphtheria
toxin production (e.g., Elek test [15]) should be performed
or the patient should be closely clinically observed for
symptoms manifestation. In our case, we opted for the
latter. If the patient presents any symptoms of toxemia,
even without the confirmation of phenotypic active toxin
production, diphtheria antitoxin should be administered as
soon as possible. Serum sickness should be ruled out by
scratch testing [20]. The antibiotic management should be
similar to the treatment for diphtheria [10]. Although the
organism is sensitive to most antibacterial agents in vitro,
erythromycin is regarded as the antibiotic of choice [1].
Since the clinical course of our patient under amoxicillin–
clavulanate treatment was favorable, we did not change the
therapy and the skin lesion healed completely. The value of
diphtheria toxoid vaccination in preventing disease caused
by toxigenic C. ulcerans has been the subject of debate [2,
21]. Previous vaccination with diphtheria toxoid did not
modify the local disease process of our patient affected
with non-toxigenic C. ulcerans. This could be explained by
the fact that the local disease may be caused by other toxins
such as the dermonecrotic toxin [1].
In conclusion, we present a very rare case of cutaneous
infection with C. ulcerans, which has potential clinical
complications similar to classic cutaneous diphtheria. All
corynebacteria isolated from wounds (if growing as pre-
dominant organisms or in pure culture) should be identified
to the species level. In case of toxigenic species such as
C. diphtheriae, C. ulcerans, and C. pseudotuberculosis,
they should be analyzed for diphtheria toxin production. If
the isolate is found to produce toxin or the patient presents
with related symptoms, the need for antitoxin administra-
tion should be evaluated immediately (in Switzerland,
antitoxin is available from the Swiss Toxicological Infor-
mation Centre, http://www.toxi.ch). Not only domestic
livestock but also pets may be responsible for the trans-
mission of this pathogen. Immunization with diphtheria
toxoid will minimize the risk of diphtheria-like disease
complications arising from infections due to toxigenic
corynebacteria [10], but it seems not to be able to avoid
non-toxigenic C. ulcerans local infections.
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